Association of age, race, and public health insurance with stage of cervical cancer at diagnosis in Brazil: Results of the EVITA cohort study (LACOG0215).

Rodrigues, Angelica Nogueira; Melo, Andréia Cristina de; Calabrich, Aknar; Cronemberger, Eduardo; Torres, Kátia Luz; Damian, Fernanda; Leal, Rachel Jorge Dino Cossetti; Azevedo, Carla; Fonseca, Allex Jardim da; Neron, Yeni Verónica; Nunes, João; Lopes, André; Thomé, F.; Leal, Renato Mazon Lima Verde; Borges, Giuliano Santos; Filho, Paulo Ricardo Santos Nunes; Zaffaroni, Facundo; Werutsky, Gustavo; Maluf, Fernando C.

doi:10.1200/jco.2018.36.15_suppl.e17509

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another important particularity is that most cervical cancer cases are diagnosed in young women (median age of 50 years) and as localised potentially curable disease [9]. Despite the relevant impact of cervical cancer, scientific research and discussions by international societies are scarce due to the low frequency of this neoplasia in places as Europe and the United States of America.…”

Section: Introductionmentioning

confidence: 99%

Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries

Estevez-Diz¹,

Bonadio²,

Miranda³

et al. 2020

ecancer

View full text Add to dashboard Cite

During the COVID-19 pandemic, health services worldwide are going through important adaptations to assist patients infected with COVID-19, at the same time as continuing to provide assistance to other potentially life-threatening diseases. Although patients with cancer may be at increased risk for severe events related to COVID-19 infection, their oncologic treatments frequently cannot be delayed for long periods without jeopardising oncologic outcomes. Considering this, a careful consideration for treatment management of different malignancies is required.Cervical cancer is concentrated mainly in low-middle income countries (LMICs), which face particular challenges during the COVID-19 pandemic due to the scarcity of health resources in many places. Although cervical cancer is the fourth cause of cancer death among women, it receives little attention from international Oncology societies and scientific research studies. In this review paper, we discuss the cervical cancer landscape and provide specialists recommendations for its management during the COVID-19 pandemic, particularly focused on LMICs' reality.

show abstract

Section: Introductionmentioning

confidence: 99%